Official Publications Vanda Pharmaceuticals Inc.
Equities
VNDA
US9216591084
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.030 USD | -2.74% |
|
-18.73% | -31.63% |
| 02-12 | Vanda Pharmaceuticals Inc files for mixed shelf offering of up to $200 million - SEC filing | RE |
| 02-12 | Vanda Pharmaceuticals Inc., Q4 2025 Earnings Call, Feb 11, 2026 |
Official Publications
No official publication found
- Stock Market
- Equities
- VNDA Stock
- News Vanda Pharmaceuticals Inc.
- Official Publications
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition